CORNERSTONE THERAPEUTICS INC Contracts & Agreements

VOTING AGREEMENT (Filed With SEC on November 7, 2013)

CORNERSTONE THERAPEUTICS INC. DESCRIPTION OF SPECIAL COMMITTEE COMPENSATION (Filed With SEC on November 7, 2013)

CORNERSTONE THERAPEUTICS INC. Restricted Stock Agreement (Filed With SEC on November 7, 2013)

AGREEMENT AND PLAN OF MERGER byand among CHIESI FARMACEUTICI S.P.A., CHIESI U.S. CORPORATION, and CORNERSTONE THERAPEUTICS INC. Dated as of September 15, 2013 CONTENTS (Filed With SEC on September 16, 2013)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2013)

LICENSE AND DISTRIBUTION AGREEMENT Parties (Filed With SEC on August 6, 2013)

SECOND AMENDMENT TO AMENDED AND RESTATED DEVELOPMENT AND MANUFACTURINGAGREEMENT (Filed With SEC on May 9, 2013)

CORNERSTONE THERAPEUTICS INC. Restricted Stock Agreement (Filed With SEC on May 9, 2013)

FIRST AMENDMENT TO THE LICENSE AND DISTRIBUTION AGREEMENT between CHIESI FARMACEUTICI S.p.A. and CORNERSTONETHERAPEUTICS INC. September 28, 2010 FIRST AMENDMENT (Filed With SEC on March 14, 2013)

AMENDMENT No. 2 to LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on March 14, 2013)

LICENSE AND DISTRIBUTIONAGREEMENT between CHIESI FARMACEUTICI S.p.A. and CORNERSTONE THERAPEUTICS INC. Dated November 6, 2012 TABLE OF CONTENTS (Filed With SEC on November 13, 2012)

Execution EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2012)

AMENDED AND RESTATED DEVELOPMENT & MANUFACTURING AGREEMENT By and Between EKR THERAPEUTICS, INC. and BAXTER HEALTHCARE CORPORATION [***]Confidential portions of the exhibit have... (Filed With SEC on August 9, 2012)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on June 27, 2012)

CREDIT AGREEMENT Dated as of June 21, 2012 among CORNERSTONE THERAPEUTICS INC., as the Borrower, CHIESI FARMACEUTICI S.P.A., as Administrative Agent, and The Other Lenders Party... (Filed With SEC on June 27, 2012)

AGREEMENT AND PLAN OF MERGER by and among Cornerstone Therapeutics Inc., Stone Acquisition Sub, Inc., EKR Holdings, Inc., and EKR Therapeutics, Inc. Dated as ofMay 14, 2012 TABLE... (Filed With SEC on May 17, 2012)

Chiesi Farmaceutici S.p.A. Via Palermo 26/1 43122 Parma, Italy (Filed With SEC on May 17, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)

CONSENT AND WAIVER (Filed With SEC on May 15, 2012)

AGREEMENT AND PLAN OF MERGER by and among CORNERSTONE THERAPEUTICS INC., COHESION MERGER SUB, INC., CARDIOKINE, INC. and SHAREHOLDERREPRESENTATIVE SERVICES LLC Dated as of... (Filed With SEC on January 4, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 6, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)

Current assets (Filed With SEC on May 12, 2011)

Leverage commercial capabilities by promoting respiratory and related products to high prescribing physicians through our respiratory sales force and to hospital-based healthcare... (Filed With SEC on March 3, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 7, 2011)

Current assets (Filed With SEC on November 4, 2010)

Current assets (Filed With SEC on August 5, 2010)

CORNERSTONE THERAPEUTICS INC. 2004 STOCK INCENTIVE PLAN (as Amended and Restated May20, 2010) (Filed With SEC on May 26, 2010)

Current assets (Filed With SEC on May 4, 2010)

EX-10.32 Amendment No. 1, dated December 18, 2009, to Supply and Marketing Agreement (Filed With SEC on March 4, 2010)

EX-10.75 Form of Restricted Stock Agreement granted under 2004 Stock Incentive Plan (Filed With SEC on March 4, 2010)

EX-10.89 Separation Letter Agreement and General Release between the Registrant and Brian Dickson dated October 16, 2009 (Filed With SEC on March 4, 2010)

EX-10.96 Executive Employment Agreement between the Registrant and Andrew K. W. Powell dated October 30, 2009 (Filed With SEC on March 4, 2010)

EX-10.2 License and Option Agreement between LG Life Sciences, Ltd. and Cornerstone BioPharma, Inc (Filed With SEC on November 4, 2009)

EX-10.3 Lease Modification Agreement No. 1, dated October 31, 2008 (Filed With SEC on November 4, 2009)

EX-10.4 Lease Modification Agreement No. 2, dated October 2, 2009 (Filed With SEC on November 4, 2009)

EX-10.5 Second Amendment, dated July 27, 2009, to Amended and Restated Restricted Stock Agreement (Filed With SEC on November 4, 2009)

Ex-10.16 Severance Agreement and General Release (Filed With SEC on August 11, 2009)

Ex-10.25 Separation Letter Agreement and General Release (Filed With SEC on August 11, 2009)

Ex-10.1 Asset Purchase Agreement, dated July 13, 2009, between Oscient Pharmaceuticals Corporation and Cornerstone BioPharma, Inc (Filed With SEC on July 17, 2009)

Ex-10.2 Amendment to Stockholders Agreement (Filed With SEC on June 29, 2009)

Ex-10.4 Amendment to Amended and Restated Executive Employment Agreement - David Price (Filed With SEC on June 29, 2009)

Ex-10.2 License and Distribution Agreement, dated of of May 6, 2009, between Chiesi Farmaceutici SpA and the Company (Filed With SEC on June 26, 2009)

EX-10.1 Amendment No. 1, dated June 16, 2009, to Development and Manufacturing Agreement (Filed With SEC on June 22, 2009)

EX-10.1 Letter Amendment, dated June 12, 2009, to Manufacturing and Supply Agreement by and among Cornerstone Therapeutics Inc., Jagotec AG and SkyePharma PLC dated August 20, 2007 (Filed With SEC on June 18, 2009)

EX-10.2 First Amendment, dated June 18, 2009, to Executive Retention Agreement between Cornerstone BioPharma, Inc. and Craig A. Collard dated February 8, 2006 (Filed With SEC on June 18, 2009)

EX-10.3 First Amendment, dated June 12, 2009, to Executive Employment Agreement between Cornerstone BioPharma, Inc. and Brian Dickson dated March 1, 2006 (Filed With SEC on June 18, 2009)

EX-10.4 First Amendment, dated June 12, 2009, to Executive Employment Agreement between Cornerstone BioPharma, Inc. and Steven Lutz dated March 1, 2006 (Filed With SEC on June 18, 2009)

EX-10.5 First Amendment, dated June 12, 2009, to Amended and Restated Restricted Stock Agreement between Cornerstone BioPharma Holdings, Inc. and David Price dated October 31, 2008 (Filed With SEC on June 18, 2009)

Ex-10.1 Cornerstone Therapeutics Inc. 2004 Stock Incentive Plan (as Amended and Restated May 28, 2009) (Filed With SEC on June 3, 2009)

EX-10.1 Stock Purchase Agreement, dated as of May 6, 2009, by and between Chiesi Farmaceutici SpA and the Company (Filed With SEC on May 12, 2009)

EX-10.2 License and Distribution Agreement, dated as of May 6, 2009, between Chiesi Farmaceutici SpA and the Company (Filed With SEC on May 12, 2009)

EX-10.3 Governance Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)

EX-10.4 Stockholders Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)

EX-10.5 Registration Rights Agreement, dated as of May 6, 2009, by and between the Company and Chiesi Farmaceutici SpA (Filed With SEC on May 12, 2009)

EX-10.6 Registration Rights Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)

EX-10.7 Voting Agreement, dated as of May 6, 2009, by and between the Company and Chiesi Farmaceutici SpA (Filed With SEC on May 12, 2009)

EX-10.8 Voting Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)

EX-10.9 Amended and Restated Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and Craig A. Collard (Filed With SEC on May 12, 2009)

EX-10.10 Amended and Restated Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and Steven M. Lutz (Filed With SEC on May 12, 2009)

EX-10.11 Amended and Restated Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and David Price (Filed With SEC on May 12, 2009)

EX-10.12 Amended and Restated Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and Brian Dickson, M.D (Filed With SEC on May 12, 2009)

EX-10.13 Amended and Restated Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and Joshua Franklin (Filed With SEC on May 12, 2009)

EX-10.14 Executive Employment Agreement, dated as of May 6, 2009, by and between the Company and Alan Roberts (Filed With SEC on May 12, 2009)

Ex-10.1 Amendment No. 2, dated May 4, 2009, to Co-Promotion and Marketing Services Agreement with Dey, L.P (Filed With SEC on May 7, 2009)

Ex-10.68 Form of Incentive Stock Option Agreement granted under 2004 Stock Incentive Plan (Filed With SEC on March 26, 2009)

Ex-10.70 Form of Nonstatutory Stock Option Agreement granted under 2004 Stock Incentive Plan (Filed With SEC on March 26, 2009)

Ex-10.72 Form of Nonstatutory Stock Option Agreement for a Non-Employee Director granted under the 2004 Stock Incentive Plan (Filed With SEC on March 26, 2009)

Ex-10.80 Amended and Restated Non-Employee Director Compensation and Reimbursement Policy of the Registrant (Filed With SEC on March 26, 2009)

EX-10.81 Agreement Regarding Employment, Employee Duties, Ownership of Employee Developments, and Confidentiality between Cornerstone BioPharma, Inc. and Joshua B. Franklin dated... (Filed With SEC on March 26, 2009)

Ex-10.87 Employment Agreement - Josh Franklin (Filed With SEC on March 26, 2009)

Ex-10.93 Restricted Stock Agreement dated as of September 16, 2008 between the Registrant and Scott B. Townsend (Filed With SEC on March 26, 2009)

Ex-10.1 Severance Agreement and General Release, dated December 22, 2008 (Filed With SEC on December 29, 2008)

Ex-4.1 Form of the Registrant's Stock Certificate (Filed With SEC on November 5, 2008)

Ex-10.1 Agreement between Patheon, Inc. (formerly known as MOVA Pharmaceutical Corporation) and Cornerstone BioPharma, Inc. dated August 8, 2007 (Filed With SEC on November 5, 2008)

Ex-10.2 Change of Scope Agreement between Patheon, Inc. (formerly known as MOVA Pharmaceutical Corporation) and Cornerstone BioPharma, Inc. dated November 20, 2007 (Filed With SEC on November 5, 2008)

Ex-10.3 Copromotion Agreement between Atley Pharmaceuticals, Inc. and Cornerstone BioPharma, Inc. dated April 2, 2007 (Filed With SEC on November 5, 2008)

Ex-10.4 First Amendment, dated July 1, 2008, to Copromotion Agreement between Atley Pharmaceuticals, Inc. and Cornerstone BioPharma, Inc. dated April 2, 2007 (Filed With SEC on November 5, 2008)

Ex-10.5 Manufacturing Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (formerly known as Cornerstone Pharmaceuticals, Inc.) dated July 20, 2004 (Filed With SEC on November 5, 2008)

Ex-10.6 License and Supply Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated October 12, 2006 (Filed With SEC on November 5, 2008)

Ex-10.7 Amendment No. 1, dated July 27, 2007, to License and Supply Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated October 12, 2006 (Filed With SEC on November 5, 2008)

Ex-10.8 Letter Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated July 27, 2007 (Filed With SEC on November 5, 2008)

Ex-10.9 Formulation Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated January 11, 2008 (Filed With SEC on November 5, 2008)

Ex-10.10 Addendum, dated August 14, 2008, to License and Supply Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated October 12, 2006 (Filed With SEC on November 5, 2008)

Ex-10.11 Joint Development Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated February 11, 2008 (Filed With SEC on November 5, 2008)

Ex-10.12 Patent License Agreement between Pharmaceutical Innovations, LLC and Cornerstone BioPharma, Inc. effective as of August 31, 2006 (Filed With SEC on November 5, 2008)

Ex-10.13 Amendment No. 1, dated August 10, 2007, to Patent License Agreement between Pharmaceutical Innovations, LLC and Cornerstone BioPharma, Inc. effective as of August 31, 2006 (Filed With SEC on November 5, 2008)

Ex-10.14 Amendment No. 2, dated February 15, 2008, to Patent License Agreement between Pharmaceutical Innovations, LLC and Cornerstone BioPharma, Inc. effective as of August 31,... (Filed With SEC on November 5, 2008)

Ex-10.15 Development, License and Services Agreement between Neos Therapeutics, L.P. and Cornerstone BioPharma, Inc. dated March 19, 2008 (Filed With SEC on November 5, 2008)

Ex-10.16 Development and Manufacturing Agreement by and among Neos Therapeutics, L.P., Coating Place, Inc. and Cornerstone BioPharma, Inc. effective February 27, 2008 (Filed With SEC on November 5, 2008)

Ex-10.17 Products Development Agreement between Neos Therapeutics, L.P. and Cornerstone BioPharma, Inc. dated August 27, 2008 (Filed With SEC on November 5, 2008)

Ex-10.18 Supply and Marketing Agreement between Sovereign Pharmaceuticals, LTD and Aristos Pharmaceuticals, Inc. dated May 1, 2008 (Filed With SEC on November 5, 2008)

Ex-10.19 Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (as assignee of Cornerstone Biopharma, Ltd. (formerly known as Cornerstone... (Filed With SEC on November 5, 2008)

Ex-10.20 Amendment No. 1, dated May 20, 2005, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (as assignee of Cornerstone... (Filed With SEC on November 5, 2008)

Ex-10.21 Amendment No. 2, dated November 16, 2005, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)

Ex-10.22 Amendment No. 2, dated November 13, 2006, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)

Ex-10.23 Amendment No. 3, dated December 7, 2006, to Asset Purchase Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc (Filed With SEC on November 5, 2008)

Ex-10.24 Lease Agreement between Regency Park Corporation and Cornerstone BioPharma, Inc. dated August 11, 2004 (Filed With SEC on November 5, 2008)

Ex-10.25 Addendum No. 1, dated January 18, 2005, to Lease Agreement between Regency Park Corporation and Cornerstone BioPharma, Inc. dated August 11, 2004 (Filed With SEC on November 5, 2008)

Ex-10.26 Lease Agreement between Crescent Lakeside, LLC and Cornerstone BioPharma Holdings, Inc. dated May 1, 2008 (Filed With SEC on November 5, 2008)

Ex-10.27 Executive Employment Agreement between Cornerstone BioPharma, Inc. and Craig A. Collard dated March 1, 2006 (Filed With SEC on November 5, 2008)

Ex-10.28 Executive Retention Agreement between Cornerstone BioPharma, Inc. and Craig A. Collard dated February 8, 2006 (Filed With SEC on November 5, 2008)

Ex-10.29 Executive Employment Agreement between Cornerstone BioPharma, Inc. and Chenyqua Baldwin dated March 1, 2006 (Filed With SEC on November 5, 2008)

Ex-10.30 Executive Employment Agreement between Cornerstone BioPharma, Inc. and Brian Dickson dated March 1, 2006 (Filed With SEC on November 5, 2008)

Ex-10.31 Agreement Regarding Employment, Employee Duties, Ownership of Employee Developments, and Confidentiality between Cornerstone BioPharma, Inc. and George Esgro dated March... (Filed With SEC on November 5, 2008)

Ex-10.32 Executive Employment Agreement between Cornerstone BioPharma, Inc. and Steven Lutz dated March 1, 2006 (Filed With SEC on November 5, 2008)

Ex-10.33 Executive Employment Agreement between Cornerstone BioPharma Holdings, Inc. and David Price dated August 20, 2008 (Filed With SEC on November 5, 2008)

Ex-10.34 Amended and Restated Restricted Stock Agreement between Cornerstone BioPharma Holdings, Inc. and David Price dated October 31, 2008 (Filed With SEC on November 5, 2008)

Ex-10.35 Form of Proprietary Information, Inventions, Non-Competition and Non-Solicitation Agreement (Filed With SEC on November 5, 2008)

Ex-10.36 Form of Indemnification Agreement, entered into between Cornerstone BioPharma Holdings, Inc. and each of Craig Collard and Alastair McEwan (Filed With SEC on November 5, 2008)

Ex-10.37 Cornerstone BioPharma Holdings, Inc. 2005 Stock Incentive Plan (as Amended and Restated effective October 31, 2008) (Filed With SEC on November 5, 2008)

Ex-10.38 Cornerstone BioPharma Holdings, Inc. 2005 Stock Option Plan (as Amended and Restated effective October 31, 2008) (Filed With SEC on November 5, 2008)

Ex-10.39 Form of Nonstatutory Stock Option Agreement Granted Under the 2005 Stock Incentive Plan (Filed With SEC on November 5, 2008)

Ex-10.40 Form of Nonstatutory Employee Stock Option Agreement Granted Under the 2005 Stock Option Plan (Filed With SEC on November 5, 2008)

Ex-10.41 Commercial Note issued by Cornerstone BioPharma Holdings, Inc. to Paragon Commercial Bank dated April 21, 2005 (Filed With SEC on November 5, 2008)

Ex-10.42 Security Agreement by Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated April 21, 2005 (Filed With SEC on November 5, 2008)

Ex-10.43 Modification Agreement, dated April 10, 2006 (Filed With SEC on November 5, 2008)

Ex-10.44 Modification Agreement, dated July 31, 2007 (Filed With SEC on November 5, 2008)

Ex-10.45 Letter Agreement, dated June 23, 2008 (Filed With SEC on November 5, 2008)

Ex-10.46 Modification Agreement, dated June 25, 2008 (Filed With SEC on November 5, 2008)

Ex-10.47 Unconditional Guaranty by Cornerstone BioPharma, Inc. in favor Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)

Ex-10.48 Security Agreement by Cornerstone BioPharma, Inc. and Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)

Ex-10.49 Unconditional Guaranty by Aristos Pharmaceuticals, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)

Ex-10.50 Security Agreement by Aristos Pharmaceuticals, Inc. and Cornerstone BioPharma Holdings, Inc. in favor of Paragon Commercial Bank dated June 25, 2008 (Filed With SEC on November 5, 2008)

Ex-10.51 Letter from Paragon Commercial Bank to Cornerstone BioPharma Holdings, Inc. dated October 29, 2008 (Filed With SEC on November 5, 2008)

EX-2.2 Amendment No.1, dated as of August 7, 2008, to Agreement and Plan of Merger, dated as of May 1, 2008 (Filed With SEC on August 11, 2008)

EX-2.4 Merger Partner Noteholder Agreement, dated as of May 1, 2008 (Filed With SEC on August 11, 2008)

EX-2.5 Amendment No. 1, dated as of August 7, 2008, to Merger Partner Noteholder Agreement, dated as of May 1, 2008 (Filed With SEC on August 11, 2008)

EX-10.2 Amendment No. 1 to Termination of Lease and Voluntary Surrender of Premises (Filed With SEC on May 12, 2008)

Ex-2.1 Agreement and Plan of Merger (Filed With SEC on May 1, 2008)

Ex-10.53 Critical Therapeutics, Inc. 2007 Cash Bonuses for Executive Officers (Filed With SEC on March 28, 2008)

Ex-10.54 Critical Therapeutics, Inc. 2008 Salaries for Executive Officers (Filed With SEC on March 28, 2008)

Ex-10.55 Critical Therapeutics, Inc. Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 28, 2008)

Ex-10.1 Manufacturing and Supply Agreement dated as of August 20, 2007 by and among the Company, Jagotec AG and SkyePharma PLC (Filed With SEC on November 9, 2007)

Ex-10.2 First Amendment dated November 5, 2007 to the Manufacturing Services Agreement by and between Patheon Pharmaceuticals Inc. and the Company dated May 9, 2007 (Filed With SEC on November 9, 2007)

Ex-10.4 Amended and Restated Employment Agreement dated November 5, 2007 by and between the Company and Frank E. Thomas (Filed With SEC on November 9, 2007)

Ex-10.5 Amended and Restated Employment Agreement dated November 6, 2007 by and between the Company and Trevor Phillips (Filed With SEC on November 9, 2007)

Ex-10.6 Amended and Restated Employment Agreement dated November 6, 2007 by and between the Company and Scott B. Townsend (Filed With SEC on November 9, 2007)

Ex-10.7 Amended and Restated Employment Agreement dated November 5, 2007 by and between the Company Jeffrey E. Young (Filed With SEC on November 9, 2007)

Ex-10.3 License and Supply Agreement (Filed With SEC on August 9, 2007)

Ex-10.4 FFIS Co-Promotion Agreement (Filed With SEC on August 9, 2007)

Ex-10.5 Amendment No. 1 to Co-Promotion and Marketing Services Agreement (Filed With SEC on August 9, 2007)

Ex-10.6 First Amendment to Exclusive License Agreement (Filed With SEC on August 9, 2007)

Ex-10.7 Amendment No. 3 to Sponsored Research and License Agreement (Filed With SEC on August 9, 2007)

EX-10.2 Co-Promotion and Marketing Services Agreement by and between the Registrant and Dey, L.P. dated March 13, 2007 (Filed With SEC on May 10, 2007)

EX-10.3 Binding Letter Agreement relating to COPD Co-Promotion by and between the Registrant and Dey, L.P. dated March 13, 2007 (Filed With SEC on May 10, 2007)

EX-10.4 Amendment No. 1, dated May 9, 2007, to Agreement for Manufacturing and Supply of Zileuton effective February 8, 2005 by and between Shasun Pharma Solutions Limited and the... (Filed With SEC on May 10, 2007)

EX-10.5 Manufacturing Services Agreement between Patheon Pharmaceuticals, Inc. and the Registrant dated May 9, 2007 (Filed With SEC on May 10, 2007)

Ex-10.8 Amendment No. 2, dated January 8, 2007, to Sponsored Research License Agreement (Filed With SEC on March 16, 2007)

Ex-10.14 Amendment No. 1, dated April 13, 2005, to License Agreement (Filed With SEC on March 16, 2007)

Ex-10.16 Amendment No. 1, dated September 15, 2004, to License Agreement (Filed With SEC on March 16, 2007)

Ex-10.38 Non-Employee Director Compensation and Reimbursement Policy (Filed With SEC on March 16, 2007)

Ex-10.42 2007 Company Goals (Filed With SEC on March 16, 2007)

Ex-10.43 Cash Bonuses for Executive Officers (Filed With SEC on March 16, 2007)

Ex-10.44 2007 Salaries for Executive Officers (Filed With SEC on March 16, 2007)

Ex-10.45 Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 16, 2007)

Ex-10.48 Amendment No. 2 to Consulting Agreement, Amendment No. 1 to Approval Agreement, and Mutual Release (Filed With SEC on March 16, 2007)

EX-10.2 - Warrant Agreement dated October 31, 2006 by and between Registrant and Mellon Investor Services (Filed With SEC on November 9, 2006)

7,455,731 CRITICAL THERAPEUTICS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on October 27, 2006)

FORMOF WARRANT AGREEMENT (Filed With SEC on October 27, 2006)

CONSULTING AGREEMENT (Filed With SEC on October 27, 2006)

EX-10.1 FOURTH LOAN MODIFICATION AGREEMENT (Filed With SEC on May 10, 2006)

Ex-10.4 Amend. No.1 to the 2004 Stock Incentive Plan (Filed With SEC on March 7, 2006)

Ex-10.19 Approval Agreement dated 3/7/06 with H. Shaw Warren, Jr. MD (Filed With SEC on March 7, 2006)

Ex-10.20 Approval Agreement dated 3/7/06 with Kevin J. Tracey, MD (Filed With SEC on March 7, 2006)

Ex-10.24 The Fourth Loan Modification Agreement dated January 6, 2006 (Filed With SEC on March 7, 2006)

Ex-10.49 Non-Employee Director Compensation and Reimbursement Policy (Filed With SEC on March 7, 2006)

Ex-10.50 Amend. No.1 to the MedImmune Exclusive License and Collaboration Agreement (Filed With SEC on March 7, 2006)

Ex-10.51 Critical Therapeutics, Inc. 2006 Company Goals (Filed With SEC on March 7, 2006)

Ex-10.52 Critical Therapeutics, Inc. 2005 Cash Bonuses for Executive Officers (Filed With SEC on March 7, 2006)

Ex-10.53 Critical Therapeutics, Inc. 2006 Salaries for Executive Officers (Filed With SEC on March 7, 2006)

Ex-10.54 Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 7, 2006)

EX-10.3 Manufacturing Services Agreement between Patheon Pharmaceuticals Inc. and Critical Therapeutics, Inc (Filed With SEC on August 12, 2005)

EX-10.4 Summary Description of Director Compensation (Filed With SEC on August 12, 2005)

EX-10.1 BECKMAN COULTER LICENSE AGREEMENT (Filed With SEC on May 12, 2005)

Ex-10.25 Feasibility Study Agreement (Filed With SEC on March 17, 2005)

Ex-10.26 Form of Incentive Stock Option Agreement (Filed With SEC on March 17, 2005)

Ex-10.27 Form of Nonstatutory Stock Option Agreement (Filed With SEC on March 17, 2005)

Ex-10.28 Form of Restricted Stock Agreement (Filed With SEC on March 17, 2005)

Ex-10.29 Form of Nonstatutory Stock Option Agreement (Filed With SEC on March 17, 2005)

Ex-10.41 Agreement for Manufacturing and Supply (Filed With SEC on March 17, 2005)

Ex-10.42 2005 Company Goals (Filed With SEC on March 17, 2005)

Ex-10.1 Standard Exclusive License Agreement (Filed With SEC on November 15, 2004)

Ex-10.2 Proposal Between Registrant and Patheon Pharmaceuticals, Inc (Filed With SEC on November 15, 2004)

Ex-10.3 Form of Nonstatutory Stock Option Agreement (Filed With SEC on November 15, 2004)

Ex-10.4 Incentive Stock Option Agreement (Paul Rubin) (Filed With SEC on November 15, 2004)

Ex-10.5 Incentive Stock Option Agreement (Trevor Philips) (Filed With SEC on November 15, 2004)

Ex-10.6 Incentive Stock Option Agreement (Walter Newman) (Filed With SEC on November 15, 2004)

Ex-10.7 Incentive Stock Option Agreement (Frederick Finnegan) (Filed With SEC on November 15, 2004)

Ex-10.8 Incentive Stock Option Agreement (Frank Thomas) (Filed With SEC on November 15, 2004)

EX-10.1 LOAN AND SECURITY AGREEMENT (Filed With SEC on August 13, 2004)

EX-10.3 SUBLEASE TERMINATION AGREEMENT (Filed With SEC on August 13, 2004)

EX-10.5 FORM OF INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on August 13, 2004)

EX-10.6 FORM OF NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on August 13, 2004)

EX-10.7 FORM OF RESTRICTED STOCK AGREEMENT (Filed With SEC on August 13, 2004)

EX-10.5 LICENSE AGREEMENT DATED 5/15/03 (Filed With SEC on May 25, 2004)

EX-10.6 SPONSORED RESEARCH & LICENSE AGMNT 7/1/03 (Filed With SEC on May 25, 2004)

EX-10.7 SPONSORED RESEARCH & LICENSE AGMNT 1/1/03 (Filed With SEC on May 25, 2004)

EX-10.9 EXCLUSIVE LICENSE AGREEMENT 12/15/00 (Filed With SEC on May 25, 2004)

EX-10.10 LICENSE AGREEMENT DATED 12/18/03 (Filed With SEC on May 25, 2004)

EX-10.11 LICENSE AGREEMENT DATED 3/17/04 (Filed With SEC on May 25, 2004)

EX-10.12 LICENSE AGREEMENT DATED 11/15/02 (Filed With SEC on May 25, 2004)

EX-1.1 FORM OF UNDERWRITING AGREEMENT (Filed With SEC on May 21, 2004)

EX-4.1 SPECIMEN CERTIFICATE (Filed With SEC on May 10, 2004)

EX-10.3 2004 STOCK INCENTIVE PLAN (Filed With SEC on May 10, 2004)

EX-10.25 DEVELOPMENT & SCALE-UP AGREEMENT (Filed With SEC on May 10, 2004)

EX-10.26 EMPLOYMENT AGREEMENT FRANK THOMAS 3/30/04 (Filed With SEC on May 10, 2004)

EX-10.1 2000 EQUITY INCENTIVE PLAN, AS AMENDED (Filed With SEC on March 19, 2004)

EX-10.2 2003 STOCK INCENTIVE PLAN, AS AMENDED (Filed With SEC on March 19, 2004)

EX-10.4 AMEND. & RESTATED INVESTOR RIGHTS AGMNT (Filed With SEC on March 19, 2004)

EX-10.5 LICENSE AGREEMENT (AMENDED MAY 15, 2003) (Filed With SEC on March 19, 2004)

EX-10.6 SPONSORED RESEARCH & LICENSE AGMNT 7/1/01 (Filed With SEC on March 19, 2004)

EX-10.7 SPONSORED RESEARCH & LICENSE AGMNT 1/1/03 (Filed With SEC on March 19, 2004)

EX-10.8 EXCLUSIVE LICENSE & COLLABORATION AGMNT (Filed With SEC on March 19, 2004)

EX-10.9 EXCLUSIVE LICENSE AGREEMENT 12/15/00 (Filed With SEC on March 19, 2004)

EX-10.10 LICENSE AGREEMENT 12/18/03 (Filed With SEC on March 19, 2004)

EX-10.11 LICENSE AGREEMENT 3/17/04 (Filed With SEC on March 19, 2004)

EX-10.12 LICENSE AGREEMENT 11/15/02 (Filed With SEC on March 19, 2004)

EX-10.13 AGREEMENT WITH JAGOTEC AG (Filed With SEC on March 19, 2004)

EX-10.14 PROPOSAL WITH RHODIA PHARMA SOLUTIONS (Filed With SEC on March 19, 2004)

EX-10.15 CONSULTING AGREEMENT H. SHAW WARREN, JR (Filed With SEC on March 19, 2004)

EX-10.16 CONSULTING AGREEMENT MITCHELL FINK, MD (Filed With SEC on March 19, 2004)

EX-10.17 CONSULTING AGREEMENT KEVIN J. TRACEY, MD (Filed With SEC on March 19, 2004)

EX-10.18 LOAN AND SECURITY AGREEMENT (Filed With SEC on March 19, 2004)

EX-10.19 ASSIGNMENT, ASSUMPTION & AMEND. OF LEASE (Filed With SEC on March 19, 2004)

EX-10.20 SUBLEASE AGREEMENT CENTAGENETIX, INC (Filed With SEC on March 19, 2004)

EX-10.21 LEASE AGREEMENT ARE-60 WESTVIEW STREET (Filed With SEC on March 19, 2004)

EX-10.22 EMPLOYMENT LETTER PAUL D. RUBIN (Filed With SEC on March 19, 2004)

EX-10.23 EMPLOYMENT LETTER RICK FINNEGAN (Filed With SEC on March 19, 2004)

EX-10.24 EMPLOYMENT LETTER WALTER NEWMAN, PH.D (Filed With SEC on March 19, 2004)

Category

Industry

Companies

Contracts

CORNERSTONE THERAPEUTICS INC Contracts & Agreements